Your browser doesn't support javascript.
loading
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate Cancer.
Wu, Cheng; Peng, Shan; Pilié, Patrick G; Geng, Chuandong; Park, Sanghee; Manyam, Ganiraju C; Lu, Yungang; Yang, Guang; Tang, Zhe; Kondraganti, Shakuntala; Wang, Daoqi; Hudgens, Courtney W; Ledesma, Debora A; Marques-Piubelli, Mario L; Torres-Cabala, Carlos A; Curry, Jonathan L; Troncoso, Patricia; Corn, Paul G; Broom, Bradley M; Thompson, Timothy C.
Afiliação
  • Wu C; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Peng S; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Pilié PG; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Geng C; Department of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, China.
  • Park S; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Manyam GC; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lu Y; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yang G; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tang Z; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kondraganti S; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang D; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hudgens CW; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ledesma DA; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Marques-Piubelli ML; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Torres-Cabala CA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Curry JL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Troncoso P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Corn PG; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Broom BM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Thompson TC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mol Cancer Ther ; 20(9): 1680-1691, 2021 09.
Article em En | MEDLINE | ID: mdl-34158347
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article